Suppr超能文献

韩国透析治疗的当前特征:聚焦糖尿病患者的2016年登记数据。

Current characteristics of dialysis therapy in Korea: 2016 registry data focusing on diabetic patients.

作者信息

Jin Dong-Chan, Yun Sung-Ro, Lee Seoung Woo, Han Sang-Woong, Kim Won, Park Jongha, Kim Yong-Kyun

机构信息

Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Department of Internal Medicine, College of Medicine, Konyang University, Daejeon, Korea.

出版信息

Kidney Res Clin Pract. 2018 Mar;37(1):20-29. doi: 10.23876/j.krcp.2018.37.1.20. Epub 2018 Mar 31.

Abstract

Diabetic nephropathy is the most frequent cause of end-stage renal disease worldwide. Dialysis patients with diabetes mellitus (DM) have more complications and shorter survival duration than non-DM dialysis patients, requiring more clinical attention and difficult management. The registry committee of the Korean Society of Nephrology has collected data about dialysis therapy in Korea through an on-line registry program and analyzed the characteristics of patients. A survey of dialysis patients in 2016 showed that 50.2% of new dialysis patients had DM nephropathy as the cause of end-stage renal disease. The proportion of patients receiving hemodialysis (HD) for more than 5 years was 38% in DM patients and 51% in non-DM patients. The mean pulse pressure in DM HD patients was 71.5 mmHg, compared with 62.6 mmHg in non-DM patients. The proportion of DM patients with native vessel arteriovenous fistula as vascular access for HD was lower than that of non-DM patients (73% vs. 78%). Mean serum creatinine of DM and non-DM dialysis patients was 8.4 mg/dL and 9.5 mg/dL respectively. As vascular access of the DM HD patients was poor, the dialysis adequacy of DM patients was slightly lower than that of non-DM patients. The 5-year survival rate for DM HD patients was 53.9%, which was much lower than that of chronic glomerulonephritis patients (78.2%). The proportion of patients with a full-time job was 17% for DM patients and 28% for non-DM patients.

摘要

糖尿病肾病是全球终末期肾病最常见的病因。糖尿病(DM)透析患者比非DM透析患者有更多并发症且生存时间更短,需要更多临床关注且管理困难。韩国肾脏病学会登记委员会通过在线登记程序收集了韩国透析治疗的数据,并分析了患者特征。2016年对透析患者的一项调查显示,50.2%的新透析患者因糖尿病肾病导致终末期肾病。糖尿病患者接受血液透析(HD)超过5年的比例为38%,非糖尿病患者为51%。糖尿病HD患者的平均脉压为71.5 mmHg,而非糖尿病患者为62.6 mmHg。糖尿病患者中以自身血管动静脉内瘘作为HD血管通路的比例低于非糖尿病患者(73%对78%)。糖尿病和非糖尿病透析患者的平均血清肌酐分别为8.4 mg/dL和9.5 mg/dL。由于糖尿病HD患者的血管通路较差,糖尿病患者的透析充分性略低于非糖尿病患者。糖尿病HD患者的5年生存率为53.9%,远低于慢性肾小球肾炎患者(78.2%)。糖尿病患者全职工作的比例为17%,非糖尿病患者为28%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db52/5875573/8634cfe3b6de/krcp-37-020f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验